IL6 and COVID-19: However, in COVID-19, heparin offers additional advantages over other anticoagulants by multiple mechanisms such as anti-inflammatory proprieties through the inhibition of neutrophil chemotaxis and neutralization of several circulating cytokines (including IL-6), complement factor, and other acute-phase reactants.